Guizhou Yibai Pharmaceutical Company Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Public

  • Employees
  • 5,509

Employees

  • Stock Symbol
  • 600594

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $0.50
  • (As of Friday Closing)

Guizhou Yibai Pharmaceutical Company General Information

Description

Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.

Contact Information

Website
www.gzcci.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No. 220-1 Baiyun Avenue
  • Guiyang, 550008
  • China
+86 0851
Primary Industry
Pharmaceuticals
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • No. 220-1 Baiyun Avenue
  • Guiyang, 550008
  • China
+86 0851

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guizhou Yibai Pharmaceutical Company Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.50 $0.52 $0.38 - $0.87 $397M 792M 10.1M -$0.02

Guizhou Yibai Pharmaceutical Company Financials Summary

In Thousands,
USD
TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 375,217 692,993 715,470 1,080,952
Revenue 348,654 398,673 406,154 518,300
EBITDA 12,234 49,188 (26,792) 75,573
Net Income (18,204) 14,615 (65,017) 37,753
Total Assets 606,175 648,542 679,349 768,304
Total Debt 131,581 139,165 156,219 141,660
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guizhou Yibai Pharmaceutical Company Patents

Guizhou Yibai Pharmaceutical Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170189367-A1 Lobaplatin crystal, preparation method and pharmaceutical application Active 20-Jun-2014
US-9889112-B2 Lobaplatin crystal, preparation method and pharmaceutical application Active 20-Jun-2014
EP-3159349-A4 Lobaplatin crystal, preparation method and pharmaceutical application Active 20-Jun-2014
EP-3159349-B1 Lobaplatin crystal, preparation method and pharmaceutical application Active 20-Jun-2014
EP-3159349-A1 Lobaplatin crystal, preparation method and pharmaceutical application Active 20-Jun-2014 A61K31/282
To view Guizhou Yibai Pharmaceutical Company’s complete patent history, request access »

Guizhou Yibai Pharmaceutical Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guizhou Yibai Pharmaceutical Company Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Deyang Cancer Hospital 26-Oct-2021 Clinics/Outpatient Services
Icon Plan 22-Jun-2016 Clinics/Outpatient Services
Hainan Changan International Pharmaceutical 13-Nov-2014 Biotechnology
Xian Jingzhan Medical Technology Company 31-Oct-2014 Medical Supplies
Horus C&K Pharma 07-Jul-2014 Merger/Acquisition Pharmaceuticals
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Guizhou Yibai Pharmaceutical Company Subsidiaries (1)

Company Name Industry Location Founded
Hainan Changan International Pharmaceutical Biotechnology Haikou, China
To view Guizhou Yibai Pharmaceutical Company’s complete subsidiaries history, request access »

Guizhou Yibai Pharmaceutical Company ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Guizhou Yibai Pharmaceutical Company’s complete esg history, request access »

Guizhou Yibai Pharmaceutical Company FAQs

  • When was Guizhou Yibai Pharmaceutical Company founded?

    Guizhou Yibai Pharmaceutical Company was founded in 1995.

  • Where is Guizhou Yibai Pharmaceutical Company headquartered?

    Guizhou Yibai Pharmaceutical Company is headquartered in Guiyang, China.

  • What is the size of Guizhou Yibai Pharmaceutical Company?

    Guizhou Yibai Pharmaceutical Company has 5,509 total employees.

  • What industry is Guizhou Yibai Pharmaceutical Company in?

    Guizhou Yibai Pharmaceutical Company’s primary industry is Pharmaceuticals.

  • Is Guizhou Yibai Pharmaceutical Company a private or public company?

    Guizhou Yibai Pharmaceutical Company is a Public company.

  • What is Guizhou Yibai Pharmaceutical Company’s stock symbol?

    The ticker symbol for Guizhou Yibai Pharmaceutical Company is 600594.

  • What is the current stock price of Guizhou Yibai Pharmaceutical Company?

    As of 11-Oct-2024 the stock price of Guizhou Yibai Pharmaceutical Company is $0.50.

  • What is the current market cap of Guizhou Yibai Pharmaceutical Company?

    The current market capitalization of Guizhou Yibai Pharmaceutical Company is $397M.

  • What is Guizhou Yibai Pharmaceutical Company’s current revenue?

    The trailing twelve month revenue for Guizhou Yibai Pharmaceutical Company is $349M.

  • What is Guizhou Yibai Pharmaceutical Company’s annual earnings per share (EPS)?

    Guizhou Yibai Pharmaceutical Company’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »